Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in: Acta Neurologica Belgica 3/2020

01-06-2020 | Colchicine | Letter to the Editor

Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever

Authors: Abdulkadir Tunç, Azize Esra Gürsoy, Vildan Güzel, Elif Gökçal, Gülsen Babacan Yıldız

Published in: Acta Neurologica Belgica | Issue 3/2020

Login to get access

Excerpt

Colchicine is primarily effective as a prophylactic treatment for familial Mediterranean fever (FMF) attacks [1]. Despite the benefits, colchicine is known to have a risk of neuromuscular toxicity [2]. Neuromuscular complications related to colchicine are axonal sensorimotor peripheral neuropathy and myopathy [2, 3]. Electrophysiologically, myotonic discharges are rarely reported during needle electromyography (EMG) testing in the literature [4‐6]. Herein, we present an extremely rare case of colchicine-induced sensorimotor neuropathy and myopathy with myotonic discharges. …
Appendix
Available only for authorised users
Literature
1.
Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75(4):644–651CrossRef
2.
Kuncl RW, Duncan G, Watson D et al (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562CrossRef
3.
Ghosh PS, Emslie-Smith AM, Dimberg EL (2014) Colchicine-induced myoneuropathy mimicking polyradiculoneuropathy. J Clin Neurosci 21(2):331–332CrossRef
4.
Rutkove SB, De Girolami U, Preston DC et al (1996) Myotonia in colchicine myoneuropathy. Muscle Nerve 19:870CrossRef
5.
Duarte J, Cabezas C, Rodríguez F et al (1998) Colchicine-induced myopathy with myotonia. Muscle Nerve 21:550CrossRef
6.
Caglar K, Odabasi Z, Safali M, Yenicesu M, Vural A (2003) Colchicine-induced myopathy with myotonia in a patient with chronic renal failure. Clin Neurol Neurosurg 105(4):274–276CrossRef
7.
Sansone VA (2016) The dystrophic and nondystrophic myotonias. Continuum (Minneap Minn) 22(6, Muscle and Neuromuscular Junction Disorders):1889–1915
Metadata
Title
Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever
Authors
Abdulkadir Tunç
Azize Esra Gürsoy
Vildan Güzel
Elif Gökçal
Gülsen Babacan Yıldız
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 3/2020
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-01070-7

Other articles of this Issue 3/2020

Acta Neurologica Belgica 3/2020 Go to the issue

Letter to the Editor

Intrathecal gadolinium-enhanced MR-cisternography for the detection of a petrous bone defect in a patient with spontaneous intraventricular pneumocephalus

Letter to the Editor

Double whammy: sex-related headache and amnesia

Original article

The effects of head posture on nerve conduction studies in patients with ankylosing spondylitis

Review article

Role of endoscopic surgical biopsy in diagnoses of intraventricular/periventricular tumors: review of literature including a monocentric case series

Review article

Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology

Letter to the Editor

Graft-versus-host disease-related neuropathy: AMAN phenotype with improvement after plasmapheresis